Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? A systematic review.
Is metabolic flexibility altered in multiple sclerosis patients?
[Understanding needs of people with Multiple Sclerosis. Perspective of patients and significant others in the German-speaking part of Switzerland].
CD8(+) T cells in multiple sclerosis.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
OPtimizing CNS drug development using molecular imaging.
Morning glory syndrome associated with multiple sclerosis.
[Special cases of multiple sclerosis].
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
Assessment and classification of early stage multiple sclerosis with inertial sensors: comparison against clinical measures of disease state.
Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis.
CUPID: Cannabinoid Use in Progressive Inflammatory brain Disease
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer.
The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Measurement and treatment of imbalance and fall risk in multiple sclerosis using the international classification of functioning, disability and health model.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?
Management of bladder dysfunction in patients with multiple sclerosis.
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
303
304
305
306
307
308
309
310
311
…
next ›
last »